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Abstract
The GAL4-UAS system is a powerful tool for manipulating gene expression, but its application in 
C. elegans has not been described. Here we systematically optimize the system’s three main 
components to develop a temperature-optimized GAL4-UAS system (cGAL) that robustly controls 
gene expression in C. elegans across 15–25°C. We demonstrate its utility in transcriptional 
reporter analysis, site-of-action experiments and exogenous transgene expression, and provide a 
basic driver and effector toolkit.
Bipartite gene expression systems offer fine spatial and temporal control of gene expression, 
and are crucial for dissecting gene function. The GAL4-UAS system, which has proven 
highly useful in Drosophila1, uses the Saccharomyces cerevisiae Gal4p protein, comprising 
a DNA-binding domain (DBD) and a transcriptional activation domain (AD). Gal4p 
homodimers bind a 17-nucleotide upstream activating sequence (UAS), resulting in 
transcription of a downstream gene2. Cell-specific promoters placed upstream of GAL4 
constitute a ‘driver’ construct, while UAS sites placed upstream of the gene of interest 
constitute an ‘effector’ construct. Incorporation of these constructs into separate transgenics 
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creates standardized driver and effector lines, which can be crossed together, generating 
progeny with desired expression patterns (Fig. 1a).
The bipartite nature of GAL4-UAS offers three major advantages over direct promoter-gene 
fusions. Large numbers of strains can be easily generated by crossing drivers and effector 
lines. Incorporating novel components into pre-existing driver and effector libraries requires 
minimal effort. Verified driver and effector strains become community reagents that foster 
experimental consistency and reproducibility. However, the GAL4-UAS system has not been 
successfully adapted for C. elegans. We optimized three components of the GAL4-UAS 
system to make it functional for C. elegans across 15–25°C, and demonstrated its robustness 
for tissue-specific gene expression, site-specific genetic rescue, and channelrhodopsin 
experiments.
Previous unpublished attempts using S. cerevisiae Gal4p DBD (residues 1–147, henceforth 
termed GAL4SC) with human herpes virus activation domain (VP16)3 as the driver 
components had poor performance in C. elegans. Since stronger activation domains improve 
performance of the GAL4 driver4, we tested VP645, which has four tandem copies of VP16. 
We fused GAL4SC to VP16 and VP64 and placed them both under the pharyngeal muscle 
promoter (Pmyo-2), designating them Pmyo-2::GAL4SC::VP16 and 
Pmyo-2::GAL4SC::VP64, respectively. Comparing their performance in a 15xUAS::gfp 
effector transgene strain (syIs300), the Pmyo-2::GAL4SC::VP64 driver yielded seven-fold 
more GFP fluorescence in pharyngeal muscles at room temperature (Fig. 1b–c). The 
fluorescence observed requires both driver and effector transgenes (Supplementary Fig. 1). 
We therefore adopted VP64 as our activation domain.
We optimized UAS copy number by comparing constructs with 5×, 10×, 15×, and 20× 
copies of UAS upstream of gfp at equal concentrations in a strain with a 
Pmyo-2::GAL4SC::VP64 driver (syIs301). We found successively increasing GFP 
fluorescence until 15xUAS copies (~2.3 fold versus 5xUAS, p<0.0001; ~1.3 fold vs. 
10xUAS, p<0.01, One-way ANOVA, Tukey’s post-test), beyond which it appeared to 
saturate (~1.1 fold versus 20xUAS, p=0.5, One-way ANOVA, Tukey’s post-test; Fig. 1d–e). 
Thus, 15xUAS was adopted for effector constructs.
To determine the robustness of our GAL4-UAS system under standard C. elegans growth 
temperatures (15–25°C), we assayed our Pmyo-2::GAL4SC::VP64 driver and 15xUAS::gfp 
effector combination, and found its transcriptional efficacy depended heavily on 
temperature, performing well only at 25°C (Fig. 2b–c; ~67% drop at 20°C, ~80% drop at 
15°C, p<0.0001, Two-way ANOVA with Tukey’s correction), consistent with findings in 
Drosophila6.
The temperature dependence of the canonical GAL4-UAS system and the optimal growth 
temperature of S. cerevisiae (30–34°C)6,7 suggested that activity of Gal4p from a specific 
yeast species may be adapted to its optimal growth temperature. Thus, a Gal4p from more 
cryophilic Saccharomyces yeast species might prove useful in designing a more robust 
driver at lower temperatures. We chose the Gal4p DBD from Saccharomyces kudriavzevii8 
(Portuguese reference strain ZP591, residues 1–147, henceforth GAL4SK) because S. 
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kudriavzevii has an optimal growth temperature (23–24°C)7 close to that of C. elegans and 
the key residues necessary for UAS binding9 are conserved between GAL4SC and GAL4SK 
(Fig. 2a).
We generated a new Pmyo-2 driver by replacing GAL4SC with GAL4SK, and compared its 
performance across 15–25°C using the same integrated 15xUAS::gfp effector strain 
(syIs300). The Pmyo-2::GAL4SK::VP64 driver lines exhibited more fluorescence than the 
Pmyo-2::GAL4SC::VP64 driver lines at room temperature; blinded researchers could 
accurately sort these two drivers using an epifluorescence dissecting microscope. We chose 
the brightest line from each for quantitation. At all temperatures, the 
Pmyo-2::GAL4SK::VP64 driver performed more robustly than the Pmyo-2::GAL4SC::VP64 
driver, in some instances comparable to strains carrying a direct Pmyo-2::gfp fusion as a 
benchmark (Fig. 2c; Supplementary Fig. 2). Our GAL4SK driver had slightly higher 
fluorescence at 25°C (Fig. 2b–c), and exhibited only a ~20% drop at 20°C (versus ~67% for 
GAL4SC), and only a ~40% drop at 15°C (versus ~80% for GAL4SC). We adopted GAL4SK 
as our DBD of choice, in conjunction with VP64 and 15xUAS, to comprise our fully 
optimized GAL4-UAS system. We designate it cGAL to denote its original implementation 
in C. elegans and its engineered performance at cooler temperatures.
We tested whether cGAL would perform in other major tissues by generating new driver 
constructs containing various tissue-specific promoters (Pnlp-40, intestine; Pmyo-3, body 
wall muscles). When injected into a strain (syIs300) with an integrated 15xUAS::gfp 
effector, these new drivers produced robust and specific GFP fluorescence in expected 
tissues (Fig. 3a–b).
However, our initial pan-neuronal (Prab-3) and GABAergic (Punc-47) drivers displayed 
poor, mosaic expression in the nervous system along with intense ectopic GFP fluorescence 
in the posterior gut (data not shown). We speculated that our vector backbone (a derivative 
of pPD49.26 containing the unc-54 3’UTR) might be responsible. We therefore switched to 
the vector pPD117.01 containing the let-858 3’UTR and a 5’ decoy sequence (comprising a 
decoy intron and ORF) upstream of the MCS (Methods; Supplementary Note 1–2); these 
modifications reduce ectopic expression and improve expression in a broad range of tissues 
(A. Fire, personal communication). We generated new Prab-3 and Punc-47 driver constructs 
in the pPD117.01 backbone and injected them into a strain (syIs390) with a new 
15xUAS::gfp::let-858 3’UTR effector (also made using pPD117.01; Supplementary Note 3–
4). These strains not only showed decreased ectopic fluorescence in the posterior gut, but 
also dramatically increased expression in the entire nervous system or GABAergic neurons, 
respectively (Fig. 3c–d; data not shown). Cholinergic (Punc-17) and glutamatergic (Peat-4) 
neuronal drivers gave similarly strong and specific results in the syIs390 effector strain (Fig. 
3e–f). Thus, cGAL is robust across a variety of tissues and we recommend using the 
pPD117.01 vector for driver and effector construction.
We then applied cGAL to functional studies by examining the rhythmic defecation motor 
program (DMP), which contains three sequential muscle contractions10. The final enteric 
muscle contraction occurs when the intestine releases neuropeptide NLP-40, which binds its 
receptor AEX-2 on GABAergic neurons, triggering an expulsion event11,12 (Fig. 3g). We 
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applied cGAL to confirm the site-of-action of aex-2 in GABAergic neurons for expulsion. 
We generated an effector line (syEx1444) with 15xUAS::aex-2(+) cDNA in the aex-2(sa3) 
background. This strain was then combined with a Pnlp-40 driver, Punc-47 driver, or 
Pmyo-3 driver to create aex-2(sa3) mutants expressing aex-2(+) cDNA specifically in the 
intestine, GABAergic neurons, or body wall muscles, respectively.
In aex-2(sa3) mutants, expulsion was nearly eliminated. Only the presence of both 
GABAergic driver and 15xUAS::aex-2(+) cDNA effector rescued the expulsion defect of 
aex-2(sa3) mutants; neither alone could (Fig. 3h). Expression of aex-2(+) cDNA in either 
body wall muscles or intestine did not rescue (Fig. 3h). These results recapitulate a study 
using conventional promoter-cDNA fusion transgenes12. Therefore, cGAL can be used for 
tissue-specific rescue experiments.
Next, we tested whether cGAL could be applied to gain-of-function experiments. 
Channelrhodopsin is a light-sensitive cation channel that depolarizes cells in the presence of 
all-trans retinal and blue light13. Activation of GABAergic neurons in C. elegans causes 
worms to adopt a flaccid, paralyzed state. We injected the GABAergic driver construct into a 
strain (syIs341) carrying an integrated 15xUAS::hChR2(H134R)::eyfp::let-858 3’UTR 
effector to express channelrhodopsin specifically in GABAergic neurons. In the presence of 
all-trans retinal, animals were subjected to a three pulse train of 475 nm blue light. Each 
excitation caused immediate, limp paralysis only in animals possessing both GABAergic 
driver and effector, but not in animals with either component alone (Fig. 3i, Supplementary 
Video 1–2 and data not shown). cGAL thus confers the ability to control exogenous 
transgene expression to dissect neural circuits in C. elegans.
Lastly, we built a basic cGAL driver and effector toolkit (Supplementary Table 1–2). For 
drivers, we constructed strains and constructs for major tissues, major neurotransmitter cell 
types, and some individual sensory neurons. For effectors, we have integrated strains for cell 
labeling (GFP, mKate2, GFP-H2B and mCherry-H2B), cell ablation (ICE), calcium 
indicator (GCaMP6s), neuronal activation (ChR2), neuronal inhibition (HisCl1) and synaptic 
inhibition (TeTx). All effectors are integrated and at least one line for each integrated 
effector was confirmed functional (Supplementary Fig. 3 and Supplementary Video 1–5).
One limitation of cGAL is the absence of Gal80p, a negative regulatory component used to 
repress Gal4p as a ‘NOT’ gate14. Gal80p recognizes the C-terminus of Gal4p15, absent in 
our drivers. Addition of the minimal C-terminal functional domain that interacts with S. 
kudriavzevii Gal80p might address this issue.
A similar bipartite expression system, Q16, has yet to be widely adopted in C. elegans, 
perhaps due to lack of sufficient strains. As with Drosophila1,17, the cGAL system could be 
combined with Q or other binary expression systems16,18–20 for control of multiple 
effectors.
cGAL can already greatly facilitate genetic site-of-action and genome-wide overexpression 
experiments, but we envision that a growing collection of drivers and effectors will allow 
analysis of genetic, developmental, and neural networks with increased rate and rigor.
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METHODS
Maintenance of C. elegans Strains
Strains were maintained on NGM plates with E. coli OP50 as the food source at room 
temperature as originally described21, unless noted otherwise. Bristol strain N2 is the wild-
type reference strain. The strains used in this study are detailed in the Supplementary Note 
5–6 and all the integrated drivers and effectors are listed in Supplementary Table 1.
Molecular Biology
Plasmids were constructed by standard molecular cloning techniques with either restriction 
enzyme cleavage and DNA ligation or Gibson assembly using enzymes from New England 
Biolabs (Beverly, MA). The coding region of GAL4SK, residues 1–147 of Gal4p from 
Saccharomyces kudriavzevii (the Portuguese reference strain ZP591, a gift from C. T. 
Hittinger), was PCR amplified from genomic DNA using 5’ primer 
ggaGCTAGCatgaagctgttgtcttcaatgg and 3’ primer cggGAATTCcggcgatacactcaactgactttggc. 
The synthetic ScaI-17mer sequence (CGGAGTACTGTCCTCCG)22 was used for the UAS 
site and was placed upstream of the pes-10 basal promoter in all effector constructs. All 
constructs were built in either the pSM1 vector (a gift from C. Bargmann), a derivative of 
pPD49.26, which contains the unc-54 3’UTR, or the vector pPD117.01 (a gift from A. Fire), 
which contains the let-858 3’UTR and a 5’ decoy minigene upstream of the MCS for 
promoter insertion (Supplementary Note 1–4 for vector maps and sequences). We generated 
effector constructs for cell labeling (GFP, mKate2, GFP-H2B and mCherry-H2B), cell 
ablation (ICE)23, calcium reporter (GCaMP6s)24, neuronal activation (ChR2)25, neuronal 
inhibition (HisCl1)26 and synaptic transmission blocking (TeTx)27. Other details about 
plasmids and oligos used in the study are documented in Supplementary Table 2.
Transformation
Transgenic animals were generated using standard microinjection techniques28. Unless 
noted otherwise, 100 ng/µL total DNA injection samples were prepared, with either the 
pBluescript II KS+ plasmid or 1 kb DNA ladder, from New England Biolabs (Beverly, MA), 
as carrier. Extrachromosomal arrays were integrated into the genome via X-ray irradiation. 
Most of the integrants were outcrossed at least three times with the wild type strain N2. Full 
details about transgenic C. elegans strains in this study are listed in the Supplementary Note 
5 and Supplementary Table 1.
Fluorescence Imaging
Approximately 25 animals per line were imaged and quantified for the optimization process 
of the cGAL system, using the myo-2 promoter (Pmyo-2). Briefly, L4 or young adults 
animals grown at corresponding temperatures (15°C, 20°C, 25°C or room temperature) were 
selected and imaged with Leica DMI600 inverted microscope equipped with a 40× oil 
objective and an Andor iXon Ultra 897 EMCCD camera, using Metamorph software 
(Molecular Devices). Images were captured with the same exposure time (20 ms) and the 
average fluorescence in the pharynx for each animal was analyzed. The representative 
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fluorescent images in Fig. 3a–f showing the application of cGAL in different tissues were 
collected with a Zeiss LSM710 confocal microscope with a 20× objective.
Defecation Motor Program Assay
L4 animals raised at room temperature were picked one day before the assay. During the 
assay, which was performed at 20°C, each individual worm was picked to a new NGM plate 
seeded with OP50 and an 18×18 mm coverslip was placed over the animal for better optics. 
After a two-minute acclimation period, each animal was videotaped using a Zeiss Stemi 
SV11 coupled to a Unibrain Fire-i 501b camera for five minutes and the number of pBoc 
and expulsion events were scored. Each pBoc indicated the initiation of each defecation 
cycle. The ratio of expulsions over pBocs was used to quantify the expulsion phenotype for 
each animal (n = 7–8 for each genotype).
Optogenetics
One day before the assay, L4 animals raised at room temperature from each strain were 
picked individually onto NGM plates, seeded with 100 µL OP50 containing 500 µM all-trans 
retinal (Sigma). During the assay, which was performed at 20°C, animals were recorded 
using a Zeiss Stemi SV11 coupled to a Unibrain Fire-i 501b camera. Channelrhodopsin was 
activated using blue light generated from a Lumen Dynamics X-Cite series 120 lamp and a 
standard GFP filter set. Blue 475 nm light intensity was measured to be 0.2 mW/mm2. After 
an initial 10-second acclimation period, three light pulses, each 2 seconds in duration, were 
delivered to each worm at intervals of 20 seconds. The researcher doing the assay was 
blinded to the genotype of the animals.
Histamine Chloride Inhibition
Histamine plates were made by adding histamine dihydrochloride (Sigma) to the standard 
NGM recipe for a final concentration of 10 mM. Animals were picked onto plates with a 
small amount of food. After 30 minutes, worms were recorded using a Zeiss Stemi SV11 
coupled to a Unibrain Fire-i 501b camera.
Statistics
For all descriptions of number of animals ‘n’ used, numbers correspond to each column 
from left to right. All bars are mean ± SEM.
Figure 1c: Two-sample Student’s t-test with Welch’s correction, as the 
Pmyo-2::GAL4SC::VP16 strain displayed much smaller variance. n = 58, 50.
Figure 1e: One-way ANOVA, with Tukey’s post-test for multiple comparisons. n = 89, 58, 
56, 60.
Figure 2c: Two-way ANOVA, comparing genotype and temperature, with Tukey’s post-test 
for multiple comparisons. n = 28, 22, 25, 26, 30, 30, 29, 27, 26.
Figure 3h: One-way ANOVA, with Tukey’s post-test for multiple comparisons. n = 8, 8, 8, 
8, 8, 7, 7.
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Figure 3i: Mann-Whitney test. n = 20, 10.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Optimization of activation domain and UAS copy number
(a) Schematic of the GAL4-UAS bipartite gene expression system. DBD: DNA-binding 
domain; AD: activation domain. Representative images (b) and quantification (c) of GFP 
fluorescence in animals carrying transgene arrays of VP16 or VP64 activation domains 
fused to the DBD of S. cerevisiae Gal4p, driving a 15xUAS:gfp effector (syIs300) using the 
Pmyo-2 pharyngeal muscle promoter. Two independent lines for each driver, n = 58, 50. 
Bars are mean ± SEM, ****p < 0.0001, two-sample t-test with Welch’s correction. 
Representative images (d) and quantification (e) of GFP fluorescence in animals carrying 
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transgene arrays of varying UAS copy number on GFP effector constructs, driven by the 
same integrated Pmyo-2::GAL4SC::VP64 driver (syIs301). 2–3 independent lines for each 
genotype, n = 89, 58, 56, 60, left to right. Bars are mean ± SEM. Scale bar is 20 µm. ** p < 
0.01 and ***p<0.001. ns, not significant. One-way ANOVA with Tukey’s post-test. a.u., 
artificial units.
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Figure 2. Designing a temperature-robust GAL4 driver via evolutionary analysis
(a) Alignment of the DNA binding domains (residues 1–147) of Gal4p sequences from S. 
cerevisiae (GAL4SC) and S. kudriavzevii (GAL4SK). Two critical UAS-interacting lysine 
residues are marked with red arrowheads. Six cysteines forming the conserved Zn2Cys6 
binuclear cluster are marked with blue arrowheads. Asterisk (*), colon (:), and period (.) 
indicate identical residues, strongly conserved residues and weakly conserved residues, 
respectively. Representative images (b) and quantification (c) of GFP fluorescence in 
animals carrying an integrated 15xUAS::gfp effector (syIs300), injected with identical 
concentrations of Pmyo-2::GAL4SC ::VP64 (syEx1434) or Pmyo-2::GAL4SK ::VP64 
(syEx1436) at 15°C, 20°C, and 25°C. A direct fusion Pmyo-2::gfp was assayed as a 
benchmark. Scale bar is 20 µm. n = 28, 22, 25, 26, 30, 30, 29, 27, 26, left to right. Bars are 
mean ± SEM. All pairwise comparisons at each temperature are significant except 
Pmyo-2::GAL4SK::VP64 and Pmyo-2::gfp at 20°C, and Pmyo-2::GAL4SC::VP64 and 
Pmyo-2::gfp at 25°C. Two-way ANOVA, Tukey’s multiple comparison test. a.u., artificial 
units.
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Figure 3. Functional studies with the cGAL system
GFP effector expression in a variety of major tissues (a–f), each driven by the indicated 
cGAL driver. In (c–f), both driver and effector constructs (15xUAS::gfp::let-858 3’UTR) are 
built in the pPD117.01 vector. (g) The signaling pathway in the circuit controlling the final 
expulsion step in the defecation motor program. AEX-2 is necessary in two GABAergic 
neurons DVB and AVL (AVL not shown) to mediate expulsion. (h) Quantification of 
expulsion events per defecation cycle in animals with indicated genotypes. aex-2 rescue 
experiments with GABAergic driver, Punc-47; muscle driver, Pmyo-3; intestinal driver, 
Pnlp-40. Bars are mean ± SEM. n = 8, 8, 8, 8, 8, 7, 7 from left to right. **** p<0.0001. ns, 
not significant. One-way ANOVA with Tukey’s post-test. (i) Quantification of paralysis in 
animals having channelrhodopsin (ChR2) specifically expressed in GABAergic neurons 
(Punc-47 driver) and exposed to blue light in the presence of all-trans retinal. Each dot 
represents mean response to three blue light exposures from an individual animal. Bars are 
mean ± SEM. n = 20 and 10, from left to right. **** p < 0.0001, Mann-Whitney test.
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